Opinion

Video

Shared Decision-Making in Cervical Cancer

Author(s):

Claire Friedman, MD,Emily Davan, RN

A gynecologic medical oncologist, a registered nurse, and a patient advocate have a conversation about shared decision-making for patients with cervical cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Salani.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
Linda Ryan, a patient advocate
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
Related Content
Biomarker testing is vital for all patients with lung cancer: © stock.adobe.com.
May 8th 2025

Biomarker Testing Remains Crucial for Young Patients With Lung Cancer

Spencer Feldman
Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks: © stock.adobe.com
April 18th 2025

Radiation Delay in NSCLC May Aid Outcomes, But Raises Toxicity Risks

Alex Biese
Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.
Kate Weissman, a gynecologic cancer survivor
November 30th 2023

Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer

Alex Biese
Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Image of doctor consulting a woman.
February 28th 2025

Chemoradiation Benefits for Cervical Cancer May Decline After Age 80

Spencer Feldman
Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study using SEER data.
Illustration of female reproductive system.
September 14th 2024

Keytruda Plus Chemoradiotherapy May Represent New Standard of Care in Cervical Cancer Subset

Kristi Rosa
Patients with previously untreated, high-risk locally advanced cervical cancer experienced improved survival when treated with Keytruda plus chemoradiotherapy.